[Double blind test on the anti-inflammatory effect of proteolytic enzymes].
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002918:Chymotrypsin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D010450:Endopeptidases / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D010113:Oxyphenbutazone / Q000627:therapeutic use; D010206:Papain / Q000627:therapeutic use; D010919:Placebos; D011183:Postoperative Complications / Q000188:drug therapy*; D013515:Surgery, Oral; D014357:Trypsin / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D010919:Placebos; D010450:Endopeptidases; D002918:Chymotrypsin; D014357:Trypsin; D010206:Papain; D010113:Oxyphenbutazone
Prueva ciega doble sobre el efecto anti-inflamatorio de enzimas proteolíticas.